首页> 美国卫生研究院文献>Journal of Korean Medical Science >Onoderas Prognostic Nutritional Index as a Risk Factor for Mortality in Peritoneal Dialysis Patients
【2h】

Onoderas Prognostic Nutritional Index as a Risk Factor for Mortality in Peritoneal Dialysis Patients

机译:Onodera的预后营养​​指数是腹膜透析患者死亡率的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to evaluate the clinical relevance and usefulness of the Onodera's prognostic nutritional index (OPNI) as a prognostic and nutritional indicator in peritoneal dialysis (PD) patients. Patients were divided into 3 groups based on the initial OPNI score: group A (n = 186, < 40), group B (n = 150, 40-45), and group C (n = 186, > 45). Group A was associated with a higher grade according to the Davies risk index than the other groups. Serum creatinine and albumin levels, total lymphocyte count, and fat mass increased with an increase in OPNI. According to the edema index, the correlation coefficient for OPNI was -0.284 and for serum albumin was -0.322. Similarly, according to the C-reactive protein (CRP), the correlation coefficient for OPNI was -0.117 and for serum albumin was -0.169. Multivariate analysis adjusted for age, Davies risk index, CRP, and edema index revealed that the hazard ratios for low OPNI, serum albumin, and CRP were 1.672 (P = 0.003), 1.308 (P = 0.130), and 1.349 (P = 0.083), respectively. Our results demonstrate that the OPNI is a simple method that can be used for predicting the nutritional status and clinical outcome in PD patients.
机译:这项研究的目的是评估Onodera的预后营养​​指数(OPNI)作为腹膜透析(PD)患者的预后和营养指标的临床相关性和实用性。根据最初的OPNI评分将患者分为3组:A组(n = 186,<40),B组(n = 150,40-45)和C组(n = 186,> 45)。根据戴维斯风险指数,与其他组相比,A组的评分更高。血清肌酐和白蛋白水平,总淋巴细胞计数和脂肪量随OPNI的增加而增加。根据水肿指数,OPNI的相关系数为-0.284,血清白蛋白的相关系数为-0.322。同样,根据C反应蛋白(CRP),OPNI的相关系数为-0.117,血清白蛋白的相关系数为-0.169。对年龄,戴维斯风险指数,CRP和水肿指数进行校正后的多因素分析显示,低OPNI,血清白蛋白和CRP的危险比为1.672(P = 0.003),1.308(P = 0.130)和1.349(P = 0.083) ), 分别。我们的结果表明,OPNI是一种可用于预测PD患者营养状况和临床结果的简单方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号